High Adherence, Microbiological Control and Reduced Exacerbations in Patients With Non-Cystic Fibrosis Bronchiectasis Treated With Nebulised Colistin. A Prospective Observational Study
Arch Bronconeumol. 2022 Dec;58(12):834-836.
doi: 10.1016/j.arbres.2022.03.023.
Epub 2022 Apr 27.
[Article in
English,
Spanish]
Authors
Belén Navas-Bueno
1
, Francisco Casas-Maldonado
2
, Alicia Padilla-Galo
3
, Enrique González-Moya-Mondelo
4
, Manuel Arenas-Gordillo
5
, Juan Carlos Bioque-Rivera
6
, Rocío Jimeno-Galván
7
, Maria Soledad Cano-Gómez
8
, Jose Luis López-Campos
8
, Silvia Merlos-Navarro
9
, Agustín Valido-Morales
10
, Jose Manuel Vaquero-Barrios
11
Affiliations
- 1 Pneumology Department, Hospital Santa Ana, Granada, Spain. Electronic address: belnabu@hotmail.com.
- 2 Pneumology Department, Hospital Universitario Clínico San Cecilio, Granada, Spain.
- 3 Pneumology Department, Hospital Costa del Sol, Málaga, Spain.
- 4 Pneumology Department, Hospital Puerta del Mar, Cádiz, Spain.
- 5 Pneumology Department, Hospital San Juan de Dios del Aljarafe, Sevilla, Spain.
- 6 Pneumology Department, Hospital Infanta Margarita, Córdoba, Spain.
- 7 Pneumology Department, Hospital Punta Europa, Cádiz, Spain.
- 8 Medical-Surgical Unit of Respiratory Diseases, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
- 9 Pneumology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain.
- 10 Pneumology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain.
- 11 Pneumology Department, Hospital Universitario Reina Sofía, Córdoba, Spain.
No abstract available
Publication types
-
Observational Study
-
Case Reports
MeSH terms
-
Administration, Inhalation
-
Anti-Bacterial Agents / therapeutic use
-
Bronchiectasis* / drug therapy
-
Colistin / therapeutic use
-
Fibrosis
-
Humans
-
Prospective Studies
-
Pseudomonas Infections* / complications
-
Pseudomonas Infections* / drug therapy
-
Pseudomonas aeruginosa
Substances
-
Colistin
-
Anti-Bacterial Agents